• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score.

作者信息

Overvad Thure Filskov, Nielsen Peter Brønnum, Lip Gregory Y H

机构信息

Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg Hospital Science and Innovation Center, Søndre Skovvej 15, 9100 Aalborg, Denmark.

Department of Cardiology, Aalborg University Hospital, Hobrovej 18-22, 9100 Aalborg, Denmark.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):37-41. doi: 10.1093/ehjcvp/pvw022. Epub 2016 Aug 12.

DOI:10.1093/ehjcvp/pvw022
PMID:27520653
Abstract
摘要

相似文献

1
Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score.心房颤动患者卒中预防的治疗阈值：关于CHA2DS2-VASc评分的观察
Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):37-41. doi: 10.1093/ehjcvp/pvw022. Epub 2016 Aug 12.
2
Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)?CHA2DS2-VASc评分为1（男性）或2（女性）的年轻房颤患者是否需要口服抗凝药？
J Am Heart Assoc. 2016 Oct 4;5(10):e003839. doi: 10.1161/JAHA.116.003839.
3
CHADS-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.用于识别真正低风险房颤卒中的CHADS-VASc评分：一项韩国全国性队列研究
Stroke. 2017 Nov;48(11):2984-2990. doi: 10.1161/STROKEAHA.117.018551. Epub 2017 Sep 22.
4
Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.CHADS2与CHA2DS2-VASc对心房颤动患者独立于抗凝治疗的中风和血栓栓塞预测的荟萃分析。
Tex Heart Inst J. 2015 Feb 1;42(1):6-15. doi: 10.14503/THIJ-14-4353. eCollection 2015 Feb.
5
Effect of suboptimal anticoagulation treatment with antiplatelet therapy and warfarin on clinical outcomes in patients with nonvalvular atrial fibrillation: A population-wide cohort study.抗血小板治疗与华法林联用的亚最佳抗凝治疗对非瓣膜性心房颤动患者临床结局的影响：一项全人群队列研究。
Heart Rhythm. 2016 Aug;13(8):1581-8. doi: 10.1016/j.hrthm.2016.03.049. Epub 2016 Mar 28.
6
Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.口服抗凝药与伴有 1 项以上卒中危险因素的心房颤动患者卒中或死亡的风险：卢瓦尔河谷心房颤动项目。
Chest. 2016 Apr;149(4):960-8. doi: 10.1378/chest.15-1622. Epub 2016 Jan 12.
7
[Atrial fibrillation and stroke].[心房颤动与中风]
Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1453-7. doi: 10.4045/tidsskr.12.0850.
8
[Characterisation of thromboembolic risk in a mexican population with non-valvular atrial fibrillation and its effect on anticoagulation (MAYA Study)].[墨西哥非瓣膜性心房颤动人群血栓栓塞风险的特征及其对抗凝治疗的影响（玛雅研究）]
Gac Med Mex. 2016 Jul-Aug;152(4):473-8.
9
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.需要透析的终末期肾病房颤患者缺血性卒中的发病率及预测
Heart Rhythm. 2014 Oct;11(10):1752-9. doi: 10.1016/j.hrthm.2014.06.021. Epub 2014 Jun 18.
10
Ischaemic stroke in patients with atrial fibrillation with chronic kidney disease undergoing peritoneal dialysis.慢性肾脏病行腹膜透析的心房颤动患者的缺血性脑卒中。
Europace. 2016 May;18(5):665-71. doi: 10.1093/europace/euv289. Epub 2015 Oct 25.

引用本文的文献

1
Impact of preprocedural anticoagulation on the incidence of silent cerebral embolisms after catheter ablation of atrial fibrillation in patients with low thromboembolic risk.低血栓栓塞风险患者房颤导管消融术前抗凝对无症状性脑栓塞发生率的影响
Front Cardiovasc Med. 2025 Apr 24;12:1559347. doi: 10.3389/fcvm.2025.1559347. eCollection 2025.
2
Comparing CHADS-VA and CHADS-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort.比较CHADS-VA和CHADS-VASc评分在房颤患者卒中风险分层中的应用：来自芬兰房颤抗凝（FinACAF）回顾性队列的时间趋势分析
Lancet Reg Health Eur. 2024 Jun 10;43:100967. doi: 10.1016/j.lanepe.2024.100967. eCollection 2024 Aug.
3
Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.女性心房颤动相关性缺血性卒中：时间趋势及其临床意义。
Eur Heart J. 2024 May 27;45(20):1819-1827. doi: 10.1093/eurheartj/ehae198.
4
Stroke and Systemic Thromboembolism according to CHADS-VASc Score in Contemporary Korean Patients with Atrial Fibrillation.当代韩国心房颤动患者根据 CHADS-VASc 评分的卒中与全身性血栓栓塞
Yonsei Med J. 2022 Apr;63(4):317-324. doi: 10.3349/ymj.2022.63.4.317.
5
Identification of Markers Associated With Development of Stroke in "Clinically Low-Risk" Atrial Fibrillation Patients.识别与“临床低危”心房颤动患者中风发展相关的标志物。
J Am Heart Assoc. 2019 Nov 5;8(21):e012697. doi: 10.1161/JAHA.119.012697. Epub 2019 Oct 31.
6
Dynamic stroke risk scores of atrial fibrillation.心房颤动的动态卒中风险评分
J Thorac Dis. 2018 Mar;10(3):1332-1334. doi: 10.21037/jtd.2018.03.35.
7
How does the TRS 2°P score relate to real-world patients?TRS 2°P评分与真实世界中的患者有怎样的关系？
Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):72-74. doi: 10.1093/ehjcvp/pvy004.
8
Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry.择期电复律时口服抗凝药物的变化：来自欧洲电复律注册研究的结果。
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):147-150. doi: 10.1093/ehjcvp/pvx003.